Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web


  Free Subscription


3 Ann Hematol
2 Biochem Biophys Res Commun
1 Blood
1 BMC Cancer
2 Cancer
1 Exp Hematol
1 Int J Hematol
3 J Clin Oncol
1 J Immunol
1 Leuk Lymphoma
2 Leuk Res
3 Leukemia

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Ann Hematol

  1. VIGNOLI A, Marchetti M, Falanga A
    Acute promyelocytic leukemia cell adhesion to vascular endothelium is reduced by heparins.
    Ann Hematol. 2018 May 1. pii: 10.1007/s00277-018-3343.
    PubMed     Text format     Abstract available

  2. HONG Y, Zhao X, Qin Y, Zhou S, et al
    The prognostic role of E2A-PBX1 expression detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) in B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
    Ann Hematol. 2018 Apr 28. pii: 10.1007/s00277-018-3338.
    PubMed     Text format     Abstract available

  3. COLTOFF A, Houldsworth J, Keyzner A, Renteria AS, et al
    Role of minimal residual disease in the management of acute myeloid leukemia-a case-based discussion.
    Ann Hematol. 2018 Apr 27. pii: 10.1007/s00277-018-3330.
    PubMed     Text format     Abstract available

    Biochem Biophys Res Commun

  4. LI Z, Luo J
    Research on epigenetic mechanism of SFRP2 in advanced chronic myeloid leukemia.
    Biochem Biophys Res Commun. 2018 Apr 25. pii: S0006-291X(18)30930.
    PubMed     Text format     Abstract available

  5. CHEN J, Li C, Zhan R, Yin Y, et al
    SPG6 supports development of acute myeloid leukemia by regulating BMPR2-Smad-Bcl-2/Bcl-xl signaling.
    Biochem Biophys Res Commun. 2018 Apr 28. pii: S0006-291X(18)31017.
    PubMed     Text format     Abstract available


  6. HRUSAK O, De Haas V, Stancikova J, Vakrmanova B, et al
    International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia.
    Blood. 2018 May 2. pii: blood-2017-12-821363. doi: 10.1182/blood-2017-12-821363.
    PubMed     Text format     Abstract available

    BMC Cancer

  7. ZHOU H, Li L, Yang P, Yang L, et al
    Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants?
    BMC Cancer. 2018;18:516.
    PubMed     Text format     Abstract available


  8. REA D, Ame S, Berger M, Cayuela JM, et al
    Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: Recommendations for clinical practice from the French Chronic Myeloid Leukemia Study Group.
    Cancer. 2018 May 3. doi: 10.1002/cncr.31411.
    PubMed     Text format     Abstract available

  9. NAQVI K, Jabbour E, Skinner J, Yilmaz M, et al
    Early results of lower dose dasatinib (50 mg daily) as frontline therapy for newly diagnosed chronic-phase chronic myeloid leukemia.
    Cancer. 2018 May 3. doi: 10.1002/cncr.31357.
    PubMed     Text format     Abstract available

    Exp Hematol

  10. THURGOOD LA, Lower KM, Macardle C, Kuss BJ, et al
    Aberrant detection of phenotypic markers in chronic lymphocytic leukemia (CLL) lymphocytes following cryopreservation.
    Exp Hematol. 2018 Apr 26. pii: S0301-472X(18)30172.
    PubMed     Text format     Abstract available

    Int J Hematol

  11. NOGUCHI S, Nakaseko C, Nishiwaki K, Ogasawara H, et al
    Switching to nilotinib is associated with deeper molecular responses in chronic myeloid leukemia chronic phase with major molecular responses to imatinib: STAT1 trial in Japan.
    Int J Hematol. 2018 Apr 30. pii: 10.1007/s12185-018-2459.
    PubMed     Text format     Abstract available

    J Clin Oncol

  12. FISHER R
    Questionable Relevance of Leukemia Risk After Radioiodine Ablation of Thyroid Cancer.
    J Clin Oncol. 2018 May 3:JCO2018781534. doi: 10.1200/JCO.2018.78.1534.
    PubMed     Text format    

  13. PICCARDO A, Puntoni M, Verburg FA, Luster M, et al
    Power of Absolute Values to Avoid Data Misinterpretations: The Case of Radioiodine-Induced Leukemia and Myelodysplasia.
    J Clin Oncol. 2018 May 3:JCO2018777318. doi: 10.1200/JCO.2018.77.7318.
    PubMed     Text format    

  14. STILGENBAUER S, Eichhorst B, Schetelig J, Hillmen P, et al
    Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial.
    J Clin Oncol. 2018 May 1:JCO2017766840. doi: 10.1200/JCO.2017.76.6840.
    PubMed     Text format     Abstract available

    J Immunol

  15. ALHAKEEM SS, McKenna MK, Oben KZ, Noothi SK, et al
    Chronic Lymphocytic Leukemia-Derived IL-10 Suppresses Antitumor Immunity.
    J Immunol. 2018 Apr 30. pii: jimmunol.1800241. doi: 10.4049/jimmunol.1800241.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  16. KRULL K, Kunstreich M, Bronsema A, Bleckmann K, et al
    Osteonecrosis in children with acute lymphoblastic leukemia at initial diagnosis and prior to any chemotherapy.
    Leuk Lymphoma. 2018 May 2:1-7. doi: 10.1080/10428194.2018.1466292.
    PubMed     Text format     Abstract available

    Leuk Res

  17. PAPAGEORGIOU SG, Kontos CK, Tsiakanikas P, Stavroulaki G, et al
    Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia.
    Leuk Res. 2018;70:1-7.
    PubMed     Text format     Abstract available

  18. TAN Y, Liu Z, Wang W, Zhu G, et al
    Monitoring of clonal evolution of double C-KIT exon 17 mutations by Droplet Digital PCR in patients with core-binding factor acute myeloid leukemia.
    Leuk Res. 2018;69:89-93.
    PubMed     Text format     Abstract available


  19. HU T, Wu Q, Chong Y, Qin H, et al
    FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndrome.
    Leukemia. 2018 Apr 2. pii: 10.1038/s41375-018-0124.
    PubMed     Text format     Abstract available

  20. PATNAIK MM, Rangit Vallapureddy, Lasho TL, Hoversten KP, et al
    A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone.
    Leukemia. 2018 Apr 2. pii: 10.1038/s41375-018-0121.
    PubMed     Text format    

  21. PASCHKA P, Schlenk RF, Weber D, Benner A, et al
    Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial.
    Leukemia. 2018 Apr 17. pii: 10.1038/s41375-018-0129.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.